221 related articles for article (PubMed ID: 25795717)
41. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
42. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
44. Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy.
Balitsky AK; Liu Y; Van der Meer PF; Heddle NM; Arnold DM
Transfusion; 2021 Jan; 61(1):286-293. PubMed ID: 33047878
[TBL] [Abstract][Full Text] [Related]
45. Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.
Ohanian M; Cancelas JA; Davenport R; Pullarkat V; Hervig T; Broome C; Marek K; Kelly M; Gul Z; Rugg N; Nestheide S; Kinne B; Szczepiorkowski Z; Kantarjian H; Pehta J; Biehl R; Yu A; Aung F; Antebi B; Fitzpatrick GM
Am J Hematol; 2022 Mar; 97(3):256-266. PubMed ID: 34748664
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
47. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
[TBL] [Abstract][Full Text] [Related]
48. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial.
Uhl L; Assmann SF; Hamza TH; Harrison RW; Gernsheimer T; Slichter SJ
Blood; 2017 Sep; 130(10):1247-1258. PubMed ID: 28679741
[TBL] [Abstract][Full Text] [Related]
49. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
50. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
Apelseth TO; Hervig T; Bruserud O
Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
[TBL] [Abstract][Full Text] [Related]
51. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
52. The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies.
Akay OM; Goren Sahin D; Andic N; Gunduz E; Karagulle M; Colak E; Gulbas Z
Transfus Apher Sci; 2015 Aug; 53(1):64-8. PubMed ID: 25818995
[TBL] [Abstract][Full Text] [Related]
53. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
[TBL] [Abstract][Full Text] [Related]
54. Platelet transfusions in haematologic malignancies in the last six months of life.
Moracchini J; Seigeot A; Angelot-Delettre F; Vienot A; Aubry R; Daguindau É; Deconinck E; Frache S; Tiberghien P
Vox Sang; 2021 Apr; 116(4):425-433. PubMed ID: 32790960
[TBL] [Abstract][Full Text] [Related]
55. Is there a standard-of-care for transfusion support of patients with haematological malignancies?
Zhao J; Edgren G; Stanworth SJ
Curr Opin Hematol; 2017 Nov; 24(6):515-520. PubMed ID: 28806272
[TBL] [Abstract][Full Text] [Related]
56. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
57. Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.
Christou G; Kekre N; Petrcich W; Tokessy M; Neurath D; Giulivi A; Saidenberg E; McDiarmid S; Atkins H; Bence-Bruckler I; Bredeson C; Huebsch L; Sabloff M; Sheppard D; Tay J; Tinmouth A; Allan DS
Transfusion; 2015 Feb; 55(2):253-8. PubMed ID: 25125085
[TBL] [Abstract][Full Text] [Related]
58. The influence of bleeding on trigger changes for platelet transfusion in patients with chemotherapy-induced thrombocytopenia.
Rioux-Massé B; Laroche V; Bowman RJ; Lindgren BR; Cohn CS; Pulkrabek SM; McCullough J
Transfusion; 2013 Feb; 53(2):306-14. PubMed ID: 22670810
[TBL] [Abstract][Full Text] [Related]
59. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
60. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
